News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Somatostatin receptor-targeted anti-cancer therapy
- Exploring vitamin D metabolism and function in cancer
- Mitochondria Transcription Factor A: A Putative Target for the Effect of Melatonin on U87MG Malignant Glioma Cell Line
- Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
- Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid
- Somatostatin receptors over-expression in castration resistant prostate cancer detected by PET/CT: preliminary report of in six patients
- Melatonin Inhibits Glioblastoma Stem-like cells through Suppression of EZH2-NOTCH1 Signaling Axis
- Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity
- Differential expression of retinoic acid receptor beta (RARbeta) and the AP-1 transcription factor in normal, premalignant and malignant human laryngeal tissues
- Dose-dependent proliferative and cytotoxic effects of melatonin on human epidermoid carcinoma and normal skin fibroblast cells
- The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women
- Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
- Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells
- Ascorbic acid and alpha-tocopherol as potent modulators on arsenic induced toxicity in mitochondria
- Melatonin promotes osteoblast differentiation by regulating Osterix protein stability and expression
- Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic Mimicry in Oral Cancer
- Clinical study of melatonin in untreatable advanced cancer patients
- Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
Most Read
- All-trans-retinoic acid and cancer
- The Di Bella Method (DBM)
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- About melatonin - 1996
- Bibliography
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Somatostatin in oncology, the overlooked evidences
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Vademecum
- Frequently Asked Questions
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathways